Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab

Journal of Clinical Neuroscience

Volumn 22, Issue 3, 2015, Pages 598-600

  Calic, Z ^a,b   Cappelen Smith, C ^a,b   Hodgkinson, S J ^a,b   McDougall, A ^a,b   Cuganesan, R ^a   Brew, B J ^c  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Fingolimod; Intravenous immunoglobulin; Natalizumab; PML IRIS

Indexed keywords

BETA INTERFERON; FINGOLIMOD; GLATIRAMER; IMMUNOGLOBULIN; JCV ANTIBODY; MEFLOQUINE; METHYLPREDNISOLONE; MIRTAZAPINE; NATALIZUMAB; UNCLASSIFIED DRUG; VIRUS ANTIBODY; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARM WEAKNESS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FACIAL NERVE PARALYSIS; FEMALE; HEADACHE; HEMIPARESIS; HUMAN; HYPERREFLEXIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; WEIGHT REDUCTION; COMPLICATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; RETREATMENT; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FINGOLIMOD HYDROCHLORIDE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MULTIPLE SCLEROSIS; NATALIZUMAB; RETREATMENT; TREATMENT OUTCOME;

EID: 84923096927     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2014.08.016     Document Type: Article

References (8)

1. B.J. Brew, N.W. Davies, and P. Cinque Progressive multifocal leukoencephalopathy and other forms of JC virus disease Nat Rev Neurol 6 2010 667 679
2. V.G. Jokubaitis, V. Li, and T. Kalincik Fingolimod after natalizumab and the risk of short-term relapse Neurology 82 2014 1204 1211
3. Fingolimod recipient develops PML, likely linked to natalizumab. React Wkly 2012;1399:3.
4. R.L. Carruthers, and J. Berger Progressive multifocal leukoencephalopathy and JC Virus-related disease in modern neurology practice Mult Scler Relat Disord 3 2014 419 430
5. D.B. Clifford, A. De Luca, and D.M. Simpson Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases Lancet Neurol 9 2010 438 446
6. P.S. Giacomini, A. Rozenberg, and I. Metz Maraviroc and JC Virus-associated immune reconstitution inflammatory syndrome N Engl J Med 370 2014 486 488
7. J. Kuhle, R. Gosert, and R. Buhler Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS Neurology 77 2011 2010 2016
8. P. Soelberg Sorensen Intravenous polyclonal human immunoglobulins in multiple sclerosis Neurodegener Dis 5 2008 8 15